128 related articles for article (PubMed ID: 31793206)
1. Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma.
Rath S; Khurana R; Sapru S; Rastogi M; Gandhi AK; Hadi R; Sahni K; Mishra SP; Srivastava AK; Syedkather F
Asia Pac J Clin Oncol; 2020 Feb; 16(1):14-22. PubMed ID: 31793206
[TBL] [Abstract][Full Text] [Related]
2. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
[TBL] [Abstract][Full Text] [Related]
3. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
4. [Prospective study of accelerated postoperative radiation therapy in patients with squamous-cell carcinoma of the head and neck].
Zouhair A; Coucke PA; Azria D; Pache P; Stupp R; Moeckli R; Mirimanoff RO; Ozsahin M
Cancer Radiother; 2003 Aug; 7(4):231-6. PubMed ID: 12914856
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
7. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
8. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
9. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
[TBL] [Abstract][Full Text] [Related]
10. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
13. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Laskar SG; Chaukar D; Deshpande M; Chatterjee A; Sinha S; Chakraborty S; Agarwal JP; Gupta T; Budrukkar A; Murthy V; Pai P; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Prabhash K; Swain M; Kumar A; Noronha V; Patil V; Joshi A; DCruz A
Eur J Cancer; 2023 Mar; 181():179-187. PubMed ID: 36669426
[TBL] [Abstract][Full Text] [Related]
14. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
15. Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.
Wennerberg J; Gebre-Medhin M; Nilsson P; Brun E; Kjellén E; Carlwig K; Reizenstein J; Kristiansson S; Söderkvist K; Wahlgren M; Zackrisson B;
Radiother Oncol; 2022 Jan; 166():26-32. PubMed ID: 34793864
[TBL] [Abstract][Full Text] [Related]
16. Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer--a feasibility study.
O'Sullivan JM; Hollywood DP; Cody N; Dillon J; Buckney S; Moriarty MJ; Armstrong JG
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):236-40. PubMed ID: 12109829
[TBL] [Abstract][Full Text] [Related]
17. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma.
Herman MP; Dagan R; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Mendenhall WM
Laryngoscope; 2015 Mar; 125(3):630-5. PubMed ID: 25376116
[TBL] [Abstract][Full Text] [Related]
19. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
[TBL] [Abstract][Full Text] [Related]
20. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck.
Trotti A; Klotch D; Endicott J; Ridley M; Greenberg H
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):13-21. PubMed ID: 8482619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
